Sign up
Log in
Why Expedia Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of Expedia Group, Inc. (NASDAQ:EXPE) rose sharply in pre-market trading after the company reported better-than-expected second-quarter financial results and issued third-quarter revenue guidance above estimates.

Expedia reported second-quarter revenue of $3.79 billion, up 6% year-over-year. The revenue beat a Street consensus estimate of $3.70 billion, according to data from Benzinga Pro. Earnings per share of $4.24 beat a Street consensus estimate of $3.90.

Expedia shares jumped 17.7% to $220.72 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) shares gained 75% to $2.10 in pre-market trading after the company announced a collaboration with Hakuhodo to participate in “World,” co-founded and chaired by OpenAI Founder Sam Altman.
  • Oriental Rise Holdings Limited (NASDAQ:ORIS) climbed 71% to $0.1542 in pre-market trading after declining 3% on Thursday.
  • Click Holdings Limited (NASDAQ:CLIK) shares jumped 32.3% to $0.4882 in pre-market trading after gaining around 9% on Thursday.
  • The RealReal, Inc. (NASDAQ:REAL) gained 30% to $7.16 in pre-market trading after the company reported better-than-expected second-quarter EPS and sales results.
  • SoundHound AI, Inc. (NASDAQ:SOUN) gained 22.4% to $13.13 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.
  • OptimizeRx Corporation (NASDAQ:OPRX) rose 20.7% to $15.46 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.
  • Ouster, Inc. (NASDAQ:OUST) rose 20.4% to $27.80 in pre-market trading after the company reported better-than-expected second-quarter financial results.
  • The Beauty Health Company (NASDAQ:SKIN) gained 18.2% to $1.88 in pre-market trading after the company reported better-than-expected quarterly financial results and raised its FY25 sales guidance.
  • JFrog Ltd. (NASDAQ:FROG) gained 16.7% to $45.25 in pre-market trading after the company reported better-than-expected second-quarter financial results and raised its FY25 sales guidance above estimates.

Losers

  • BioVie Inc. (NASDAQ:BIVI) dipped 44% to $1.63 in pre-market trading after the company reported the pricing of $12 million public offering.
  • The Trade Desk, Inc. (NASDAQ:TTD) declined 29.6% to $62.19 in pre-market trading after the company reported second-quarter financial results.
  • Iovance Biotherapeutics, Inc (NASDAQ:IOVA) fell 26.9% to $1.93 in pre-market trading after the company reported worse-than-expected second-quarter financial results and issued FY25 sales guidance below estimates.
  • Sweetgreen, Inc. (NYSE:SG) fell 23.5% to $9.69 in pre-market trading after the company reported worse-than-expected second-quarter financial results and cut its FY25 sales guidance below estimates.
  • iSpecimen Inc. (NASDAQ:ISPC) fell 22.8% to $1.39 in pre-market trading after gaining more than 6% on Thursday.
  • Sensus Healthcare, Inc. (NASDAQ:SRTS) dipped 21.5% to $4.20 in pre-market trading after the company reported worse-than-expected quarterly financial results.
  • Xponential Fitness, Inc. (NYSE:XPOF) declined 21.1% to $7.59 in pre-market trading after the company reported downbeat quarterly sales and slashed its FY2025 sales guidance.
  • Sezzle Inc. (NASDAQ:SEZL) shares fell 20.3% to $111.05 in pre-market trading following the release of its second-quarter financial results.
  • Twilio Inc. (NYSE:TWLO) shares tumbled 12.8% to $106.75 in pre-market trading after the company issued third-quarter guidance below estimates.
  • Pinterest, Inc. (NYSE:PINS) fell 12.4% to $34.35 in pre-market trading after the company reported worse-than-expected second-quarter adjusted EPS results.

Now Read This:

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.